Drug Trial Radar · NCT04675151
Safety and Efficacy of Nyxol With Pilocarpine Eye Drops in Subjects With Presbyopia
Last checked: Nov 20, 2026Latest source record: Oct 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
150
Actual
Start
Feb 15, 2021
Primary completion
May 17, 2021
Study completion Jun 30, 2021
Sponsor
- Lead sponsor
- Opus Genetics, IncIndustry
- Sponsor type
- Industry
- First posted
- Dec 19, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 40 years, up to 64 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objectives of this study are: To evaluate the efficacy of Nyxol + Pilocarpine to improve DCNVA in subjects with presbyopia
Conditions
- Presbyopia
Interventions
Phentolamine Ophthalmic Solution 0.75%Drug
0.75% phentolamine ophthalmic solution (Nyxol), a non-selective alpha-1 and alpha-2 adrenergic antagonist
PilocarpineDrug
Pilocarpine ophthalmic solution
PlaceboOther
Topical sterile ophthalmic solution
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent of Subjects With ≥ 15 Letters of Improvement in Photopic Binocular DCNVATime frame: Visit 2 at 1 hour
Locations
17 sites in 1 country. Site status is shown where the registry gives one.
Clinical Site 12
Laguna Hills, California
Clinical Site 6
Newport Beach, California
Clinical Site 13
Crystal River, Florida
Clinical Site 5
Longwood, Florida
Clinical Site 11
Maitland, Florida
Clinical Site 8
Sarasota, Florida
Clinical Site 10
Roswell, Georgia
Clinical Site 3
Pittsburg, Kansas
Clinical Site 18
St Louis, Missouri
Clinical Site 16
Poughkeepsie, New York
Clinical Site 14
Fargo, North Dakota
Clinical Site 2
Athens, Ohio
Clinical Site 9
Cincinnati, Ohio
Clinical Site 7
Cleveland, Ohio
Clinical Site 15
Powell, Ohio
Clinical Site 4
Warwick, Rhode Island
Clinical Site 1
Memphis, Tennessee
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.